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Summary
In recent years, it has been shown that the central pressure correlated with cardiovascular risk and, better than pe-
ripheral pressure, provides the risk of serious cardiovascular events. It is known that blood pressure and pulse wave 
shape are different in different sections of the arterial tree. This difference is related to the age sex, incidence of heart 
disease, concomitant cardiovascular disease, diabetes, renal failure, used drugs. In young people, with flexible walls of 
the vessels, the difference between the circumferential pressure, measured at the upper limb and the central pressure 
can range from a few to over twenty mmHg. In this context, we present a case of a young patient with hypertension 
treated with antihypertensive fixed dose combination drug.
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23-year-old patient with arterial hypertension dia-
gnosed a year ago was admitted to the Hyperten-
sion Department for the purpose of diagnostic tests 
for secondary causes of hypertension. The patient 
complained of unstable blood pressure, periodic in-
creases in BP to 160/100 mmHg, despite regular 
treatment with metoprolol 50 mg daily. 6 weeks 
before the scheduled diagnostics, patient set oral 
hormonal contraceptive preparations. The examina-
tion revealed overweight, pale skin, stretch marks on 
thighs, mid-systolic click in mitral valve auscultation 
area, and high blood pressure.
There was no significant deviations in the laboratory 
tests (serum: sodium: 141 mmol/l [N: 135–145], po-
tassium 4.90 mmol/l [N: 3.50–5.50]; sodium and po-
tassium in the urine collection: sodium 168.30 mmol/ 
/24h [N: 40.00–220.00], potassium 55.73 mmol/24h 
[N: 25.00–125.00]; microalbuminuria: 8.10 mg/day 
[N: < 30.00 mg/24h]; ACR 3.48 mg/g; plasma 
renin activity: 3.37 ng/ml/h [N: 0.51–2.64]; plas-
ma renin activity after administration of 2000 ml 
of 0.9% NaCl: 1.09 ng/ml/h [N: 0.26–1.32]; al-
dosterone — basic conditions: 102.00 pg/ml 
[N: 10–160]; aldosterone after administration of 
2000 ml of 0.9% NaCl: 35.00 pg/ml [N: 6–75]; 
metanephrine urine collection: 18 g/24 h [N: 350]). 
The test results did not reveal potential causes of 
secondary of hypertension. Only echocardiography 
revealed flabby anterior leaflet of mitral valve. An-
gio-CT of the abdomen revealed a small, 2 mm 
lodgement in the right renal upper calyx (Figure 1). 
The average Ambulatory Blood Pressure Moni-
toring (ABPM) blood pressure values were: 141/ 
/85 mmHg, up to 184/113 mmHg (Figure 2). The 
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Figure 1. Angio-CT of the abdomen revealed a small, 2 mm, lodge-
ment in right renal upper calyx (Source: Department of Diagnostic 
Imaging and Interventional Radiology, Pomeranian Medical Univer-
sity, Szczecin, 2014. Courtesy of Prof. Walecka)
Figure 2. ABPM before modifying treatment: metoprolol 50 mg/day (Source: Department of Hypertensiology and Internal Medicine,  
Pomeranian Medical University, 2014)
Figure 3. ABPM after modification of treatment: bisoprolol/amlopdypine 5/5 mg/day (Source: Department of Hypertensiology and Internal  
Medicine, Pomeranian Medical University, 2014)
patient was discharged home with the instruction 
to take antihypertensive therapy — combined 
preparation of bisoprolol and amlodipine in daily 
doses of 5 and 5 mg. Follow-up ABPM, taken after 
2 months, showed marked improvement (Figure 3). 
Importantly, pulse wave analysis conducted using 
the applanation tonometry method showed normal-
ization of central pressure, compared with baseline 
examination (Figure 4).
In recent years, it has been shown that the cen-
tral pressure correlated with cardiovascular risk and, 
better than peripheral pressure, predicts the risk of 
serious cardiovascular events [1–6]. It is known that 
blood pressure and pulse wave shape are different in 
different sections of the arterial tree. This difference 
is related to the age, sex, incidence of heart disease, 
concomitant cardiovascular disease, diabetes, renal 
failure, and used drugs [1, 7]. In young people, with 
flexible walls of the vessels, the difference between 
the peripheral pressure, measured at the upper limb, 
and the central pressure can range from a few to over 
twenty mmHg [1, 8]. The result achieved in our 
patient seems to be consistent with current scien-
tific reports, which clearly confirms the differences 
in effect on central pressure of different groups 
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Figure 4. The central pressure curve (Source: Department of Hypertensiology and Internal Medicine, 2014)
of antihypertensive drugs. In this context, have 
a beneficial effect of angiotensin-converting enzyme 
inhibitors (ACEI), beta-blockers and amlodipine 
[9–11]. The first mechanism leading to differences 
is possible different effects of different drug classes 
on the speed of the pulse wave velocity (PWV) (best 
documented is beneficial effect of ACEI on PWV). 
The second mechanism is the ability to change 
the pressure wave reflection site distance under the 
influence of drugs used. Vasodilators such as angio-
tensin converting enzyme inhibitors, angiotensin 
receptor blockers or calcium channel blockers move 
away wave reflection points, while vasoconstrictor 
drugs and most of the beta-blockers and diuretics 
— bring them closer. A third potential mechanism 
is the extended duration of the contraction of the 
left ventricle as a result of the negative chronotropic 
action of some drugs (beta-blockers and calcium 
channel blockers) [14].
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